Diagnosis and management of delirium

CONTINUUM Lifelong Learning in Neurology

Volumn 12, Issue 5, 2006, Pages 15-32

  Bourgeois, James A ^a,b   Seritan, Andreea ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; ANTIPARKINSON AGENT; ARIPIPRAZOLE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CARDIOVASCULAR AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; GASTROINTESTINAL AGENT; HALOPERIDOL; IMMUNOSUPPRESSIVE AGENT; MIANSERIN; MUSCLE RELAXANT AGENT; NEUROLEPTIC AGENT; NEUROTRANSMITTER; OLANZAPINE; ONDANSETRON; OPIATE; PHYSOSTIGMINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; SEDATIVE AGENT; THIORIDAZINE; TRAZODONE; UNINDEXED DRUG; VALPROIC ACID; ZIPRASIDONE;

AGITATION; ANXIETY DISORDER; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL EXAMINATION; CLINICAL TRIAL; COGNITIVE DEFECT; DELIRIUM; DEPRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG INDICATION; EXTRAPYRAMIDAL SYMPTOM; HEART VENTRICLE EXTRASYSTOLE; HUMAN; MORBIDITY; PATHOGENESIS; PATHOPHYSIOLOGY; PROGNOSIS; PSYCHOSIS; QT PROLONGATION; REVIEW; SEDATION; SIDE EFFECT;

EID: 33749665789     PISSN: 10802371     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.CON.0000290498.73645.50     Document Type: Review

References (42)

1. ▶ American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition, text revision. Washington, DC: American Psychiatric Association, 2000.
2. ▶ Bayindir O, Akpinar B, Can E, et al. The use of the 5-HT3-receptor antagonist ondansetron for the treatment of postcardiotomy delirium. J Cardiothorac Vasc Anesth 2000;14:288-292. A study of ondansetron for delirium found a single dose of 8 mg to be effective.
3. ▶ Bourgeois JA, Koike AK, Simmons JE, et al. Adjunctive valproic acid for delirium and/or agitation on a consultation-liaison service: a report of six cases. J Neuropsychiatry Clin Neurosci 2005;17:232-238. Six cases with complex or prolonged delirium received intravenous (IV) or by mouth (PO) valproate adjunctively to help manage delirium and agitation.
4. ▶ Breitbart W, Gibson C, Tremblay A. The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses. Psychosomatics 2002a;43:183-194. Patients' memories of delirium episodes are frequently distressing. Delirium episodes are also distressing to family members.
5. ▶ Breitbart W, Rosenfeld B, Roth A, et al. The Memorial Delirium Assessment Scale. J Pain Symptom Manage 1997;13:128-137. Two studies of medically hospitalized patients were conducted to assess the reliability and validity of a new measure of delirium severity.
6. ▶ Breitbart W, Tremblay A, Gibson C. An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. Psychosomatics 2002b;43:175-182. A trial of olanzapine for delirium in cancer found it effective; 30% of patients experienced sedation. Olanzapine is an alternative to haloperidol.
7. ▶ Burns A, Gallagley A, Byrne J. Delirium. J Neurol Neurosurg Psychiatry 2004;75:362-367. An extended review of delirium diagnosis and management from a psychiatric perspective.
8. ▶ Caeiro L, Ferro JM, Claro MI, et al. Delirium in acute stroke: a preliminary study of the role of anticholinergic medications. Eur J Neurol 2004; 11:699-704. A study that showed increased risk of delirium post-cerebrovascular accident in patients with use of anticholinergics.
9. ▶ Chen B, Cardasis W. Delirium induced by lithium and risperidone combination. Am J Psychiatry 1996;153:1233-1234. A case report of delirium in the context of risperidone and lithium treatment in an elderly patient.
10. ▶ Cole MG, Dendukuri N, McCusker J, Han L. An empirical study of different diagnostic criteria for delirium among elderly medical inpatients. J Neuropsychiatry Clin Neurosci 2003;15:200-207. Comparison study showed that more-inclusive delirium diagnostic criteria (eg, Diagnostic and Statistical Manual of Mental Disorders criteria) more accurately capture hypoactive-delirium cases.
11. ▶ de Jonge P, Huyse FJ, Herzog T, et al. Referral pattern of neurological patients to psychiatric consultation-liaison services in 33 European hospitals. Gen Hosp Psychiatry 2001;23:152-157. A European study of referral patterns to consultation-liaison psychiatry in Europe showed that a significant percentage of neurology patients referred for psychiatric consultation present with cognitive and other ''organic'' impairment.
12. ▶ Doig A, Sembhi S, Livingston G. Acute confusional states during treatment with risperidone. Int J Geriatr Psychiatry 2000;15:534-535. Case report of delirium apparently resulting from risperidone treatment in an elderly male.
13. ▶ Engel GL, Romano J. Delirium, a syndrome of cerebral insufficiency. 1959. J Neuropsychiatry Clin Neurosci 2004;16:526-538. Classic article of phenomenology and pathophysiology of delirium.
14. ▶ Gaudreau JD, Gagnon P. Psychotogenic drugs and delirium pathogenesis: the central role of the thalamus. Med Hypotheses 2005;64:471-475. A provocative model for delirium pathophysiology relating multiple neurotransmitter system alterations with thalamic "gating" model.
15. ▶ Glassman AH, Bigger JT Jr. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry 2001;158:1774-1782. Major review of the issues of antipsychotic drugs and QT corrected for heart rate (QTc) prolongation, torsade des pointes, and sudden cardiac death.
16. ▶ Han CS, Kim YK. A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 2004;45:297-301. A study that showed risperidone was equally effective as haloperidol in the treatment of delirium.
17. ▶ Hogarth DK, Hall J. Management of sedation in mechanically ventilated patients. Curr Opin Crit Care 2004;10:40-46. A review of multiple agents of interest in sedation of critically ill patients, overlaps with delirium management; compares several different medication classes.
18. ▶ Jacobi J, Fraser GL, Coursin DB, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002;30:119-141. Extensive review of several different classes of medications for sedation and analgesia in the intensive care unit setting.
19. ▶ Kane JM, Eerdekens M, Lindenmayer JP, et al. Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic. Am J Psychiatry 2003;160:1125-1132. An early study of long-acting risperidone, dosing, and clinical effectiveness.
20. ▶ Leso L, Schwartz TL. Ziprasidone treatment of delirium. Psychosomatics 2002;43:61-62. A case report of ziprasidone for delirium in a patient at risk for movement disorder from other antipsychotics.
21. ▶ Meagher DJ. Delirium: optimising management. BMJ 2001;322:144-149. A recent major review of diagnosis and management of delirium written by a consultant psychiatrist.
22. ▶ Mittal D, Jimerson NA, Neely EP, et al. Risperidone in the treatment of delirium: results from a prospective open-label trial. J Clin Psychiatry 2004;65:662-667. Study that found risperidone effective and safe as monotherapy for delirium, including no cases experiencing movement disorders.
23. ▶ Parellada E, Baeza I, de Pablo J, Martinez G. Risperidone in the treatment of patients with delirium. J Clin Psychiatry 2004;65:348-353. Study of risperidone as monotherapy for delirium with good clinical efficacy and safety; no patients experienced extrapyramidal symptoms (EPSs).
24. ▶ Ravona-Springer R, Dolberg OT, Hirschmann S, Grunhaus L. Delirium in elderly patients treated with risperidone: a report of three cases. J Clin Psychopharmacol 1998;18:171-172. Case series of apparent risperidone-induced delirium in three elderly patients.
25. ▶ Rincon HG, Granados M, Unutzer J, et al. Prevalence, detection and treatment of anxiety, depression, and delirium in the adult critical care unit. Psychosomatics 2001;42:391-396. Prospective study found delirium in 7% of intensive care unit admissions.
26. ▶ Samuels SC, Evers MM. Delirium. Pragmatic guidance for managing a common, confounding, and sometimes lethal condition. Geriatrics 2002;57:33-38. Concise review of diagnosis and management of delirium from a geriatrics perspective.
27. ▶ Saravay SM, Kaplowitz M, Kurek J, et al. How do delirium and dementia increase length of stay of elderly general medical inpatients? Psychosomatics 2004;45:235-242. Study showed that elderly patients with delirium and dementia have increased length of stay substantially due to cognitive symptoms that precede behavioral problems.
28. ▶ Saravay SM, Lavin M. Psychiatric comorbidity and length of stay in the general hospital. A critical review of outcome studies. Psychosomatics 1994;35:233-252. Major review of psychiatric consultation-liaison outcome studies showed that cognitively impaired patients (with both delirium and dementia) have longer hospital length of stay.
29. ▶ Sasaki Y, Matsuyama T, Inoue S, et al. A prospective, open-label, flexible-dose study of quetiapine in the treatment of delirium. J Clin Psychiatry 2003;63:1316-1321. A study of quetiapine for delirium (mean dose 44.9 mg/d) showed clinical effectiveness and favorable safety profile.
30. ▶ Schrag A. Psychiatric aspects of Parkinson's disease - an update. J Neurol 2004;251:795-804. A comprehensive review of psychiatric comorbidity in Parkinson's disease.
31. ▶ Schwartz TL, Masand PS. The role of atypical antipsychotics in the treatment of delirium. Psychosomatics 2002;43:171-174. A review of the growing literature on atypical antipsychotics for delirium and their relative safety and effectiveness.
32. ▶ Sipahimalani A, Masand PS. Olanzapine in the treatment of delirium. Psychosomatics 1998;39:422-430. A study of olanzapine versus haloperidol for delirium showed clinical efficacy and a favorable safety experience for olanzapine, while the majority of the haloperidol patients experienced EPS or sedation.
33. ▶ Tavcar R, Dernovsek MZ. Risperidone-induced delirium. Can J Psychiatry 1998;43:194. A case report of delirium following risperidone use in an elderly female patient.
34. ▶ Torres R, Mittal D, Kennedy R. Use of quetiapine in delirium: case reports. Psychosomatics 2001;42:347-349. A case series of two patients with delirium successfully treated with quetiapine.
35. ▶ Trzepacz PT. Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine. Semin Clin Neuropsychiatry 2000;5:13-148. Acetylcholine deficiency and dopamine excess - absolute and/or relative to each other-appear to be critical in the final common pathway of delirium.
36. ▶ Trzepacz PT, Mittal D, Torres R, et al. Validation of the Delirium Rating Scale-revised-98: comparison with the delirium rating scale and the cognitive test for delirium. J Neuropsychiatry Clin Neurosci 2001;13:229-242. Validation of the modified version of the Delirium Rating Scale for clinical use in delirium diagnosis and monitoring.
37. ▶ Tune LE. Anticholinergic effects of medication in elderly patients. J Clin Psychiatry 2001;62:11-14. Review of the cognitive toxicity following anticholinergic medications in elderly patients.
38. ▶ Turkel SB, Tavare CJ. Delirium in children and adolescents. J Neuropsychiatry Clin Neurosci 2003;15:431-435. Study showed that the phenomenology of delirium in children resembles that in adults, although psychosis and disorientation are less characteristic. Lengths of stay and mortality are high in patients with delirium.
39. ▶ US Food and Drug Administration. FDA Public Health Advisory: Deaths with antipsychotics in elderly patients with behavioral disturbances. [online] 2005 [cited March 7, 2006]. Available from: http://www.fda.gov/cder/ drug/ advisory/antipsychotics.htm.
40. ▶ US Food and Drug Administration Psychopharmacological Drugs Advisory Committee. Briefing document for Zeldox capsules (Ziprasidone HCl). [online] 2000 [cited March 7, 2006]. Available from: http://www.fda.gov/ ohrms/dockets/ac/00/backgrd/3619b1a.pdf. Study outlining QTc prolongation intervals with several antipsychotics.
41. ▶ Weber JB, Coverdale JH, Kunik ME. Delirium: current trends in prevention and treatment. Intern Med J 2004;34:115-121. Comprehensive review of diagnosis and management of delirium from a general medical perspective, including reviews of clinical trials for prevention and treatment.
42. ▶ Young CC, Lujan E. Intravenous ziprasidone for treatment of delirium in the intensive care unit. Anesthesiology 2004;101:794-795. Case report of intravenous use of ziprasidone in a patient in the intensive care unit.